Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VXRT |
---|---|---|
09:32 ET | 56279 | 3.5 |
09:34 ET | 18929 | 3.51 |
09:36 ET | 15912 | 3.505 |
09:38 ET | 13316 | 3.52 |
09:39 ET | 4686 | 3.5 |
09:41 ET | 5118 | 3.51 |
09:43 ET | 4402 | 3.56 |
09:45 ET | 3270 | 3.56 |
09:48 ET | 2668 | 3.575 |
09:50 ET | 1730 | 3.585 |
09:52 ET | 13900 | 3.6299 |
09:54 ET | 22511 | 3.65 |
09:56 ET | 10852 | 3.625 |
09:57 ET | 27268 | 3.63 |
09:59 ET | 6320 | 3.63 |
10:01 ET | 8715 | 3.64 |
10:03 ET | 15085 | 3.615 |
10:06 ET | 14490 | 3.625 |
10:08 ET | 2503 | 3.64 |
10:10 ET | 12730 | 3.645 |
10:12 ET | 32347 | 3.63 |
10:14 ET | 25414 | 3.6409 |
10:15 ET | 28914 | 3.64 |
10:17 ET | 10800 | 3.64 |
10:19 ET | 8468 | 3.68 |
10:21 ET | 7257 | 3.69 |
10:24 ET | 6435 | 3.7058 |
10:26 ET | 4800 | 3.68 |
10:28 ET | 19369 | 3.6407 |
10:30 ET | 3787 | 3.63 |
10:32 ET | 14000 | 3.625 |
10:33 ET | 4300 | 3.63 |
10:35 ET | 2300 | 3.62 |
10:37 ET | 1755 | 3.6 |
10:39 ET | 7517 | 3.5991 |
10:42 ET | 4900 | 3.58 |
10:44 ET | 3796 | 3.59 |
10:46 ET | 2713 | 3.61 |
10:48 ET | 1300 | 3.62 |
10:50 ET | 7637 | 3.62 |
10:51 ET | 1392 | 3.6 |
10:53 ET | 6401 | 3.61 |
10:55 ET | 1400 | 3.62 |
10:57 ET | 6800 | 3.65 |
11:00 ET | 700 | 3.655 |
11:02 ET | 7282 | 3.6406 |
11:04 ET | 16090 | 3.6421 |
11:06 ET | 825 | 3.655 |
11:08 ET | 3349 | 3.66 |
11:09 ET | 8419 | 3.69 |
11:11 ET | 12116 | 3.69 |
11:13 ET | 1500 | 3.7 |
11:15 ET | 3007 | 3.72 |
11:18 ET | 17550 | 3.74 |
11:20 ET | 3875 | 3.72 |
11:22 ET | 2737 | 3.715 |
11:24 ET | 3304 | 3.715 |
11:26 ET | 3700 | 3.7107 |
11:27 ET | 4377 | 3.72 |
11:29 ET | 3294 | 3.71 |
11:31 ET | 4873 | 3.7199 |
11:33 ET | 3207 | 3.7112 |
11:36 ET | 1800 | 3.73 |
11:38 ET | 25891 | 3.7299 |
11:40 ET | 6782 | 3.725 |
11:42 ET | 4400 | 3.735 |
11:44 ET | 3889 | 3.73 |
11:45 ET | 5700 | 3.71 |
11:47 ET | 2300 | 3.715 |
11:49 ET | 10685 | 3.6807 |
11:51 ET | 5611 | 3.66 |
11:54 ET | 10881 | 3.655 |
11:56 ET | 2547 | 3.6799 |
11:58 ET | 1254 | 3.678 |
12:00 ET | 6505 | 3.675 |
12:02 ET | 1100 | 3.665 |
12:03 ET | 11564 | 3.655 |
12:05 ET | 2500 | 3.66 |
12:07 ET | 12897 | 3.66 |
12:09 ET | 1650 | 3.6597 |
12:12 ET | 4200 | 3.6599 |
12:14 ET | 1300 | 3.659 |
12:16 ET | 3300 | 3.66 |
12:18 ET | 7290 | 3.67 |
12:20 ET | 6521 | 3.685 |
12:21 ET | 13402 | 3.695 |
12:23 ET | 4501 | 3.69 |
12:25 ET | 4800 | 3.685 |
12:27 ET | 1100 | 3.7 |
12:30 ET | 1050 | 3.698 |
12:32 ET | 300 | 3.695 |
12:34 ET | 2650 | 3.685 |
12:36 ET | 3300 | 3.68 |
12:38 ET | 5160 | 3.67 |
12:39 ET | 3901 | 3.6699 |
12:41 ET | 852 | 3.66 |
12:43 ET | 5162 | 3.665 |
12:45 ET | 1527 | 3.66 |
12:48 ET | 4900 | 3.655 |
12:50 ET | 1475 | 3.66 |
12:52 ET | 300 | 3.67 |
12:54 ET | 1050 | 3.665 |
12:56 ET | 8656 | 3.66 |
12:57 ET | 9423 | 3.64 |
12:59 ET | 3397 | 3.62 |
01:01 ET | 5250 | 3.62 |
01:03 ET | 1113 | 3.605 |
01:06 ET | 400 | 3.6 |
01:08 ET | 13414 | 3.595 |
01:10 ET | 1300 | 3.6 |
01:12 ET | 2777 | 3.615 |
01:14 ET | 400 | 3.615 |
01:15 ET | 4513 | 3.635 |
01:17 ET | 2974 | 3.615 |
01:19 ET | 250 | 3.62 |
01:21 ET | 680 | 3.63 |
01:24 ET | 300 | 3.625 |
01:26 ET | 4900 | 3.63 |
01:28 ET | 833 | 3.625 |
01:30 ET | 2220 | 3.635 |
01:32 ET | 3000 | 3.64 |
01:33 ET | 2101 | 3.645 |
01:35 ET | 1800 | 3.6424 |
01:37 ET | 800 | 3.645 |
01:39 ET | 5002 | 3.66 |
01:42 ET | 3000 | 3.65 |
01:44 ET | 3400 | 3.65 |
01:46 ET | 800 | 3.655 |
01:48 ET | 3555 | 3.655 |
01:50 ET | 300 | 3.66 |
01:51 ET | 5669 | 3.665 |
01:53 ET | 600 | 3.66 |
01:55 ET | 3662 | 3.6601 |
01:57 ET | 1300 | 3.66 |
02:00 ET | 500 | 3.66 |
02:02 ET | 300 | 3.6536 |
02:04 ET | 4604 | 3.65 |
02:06 ET | 2900 | 3.65 |
02:08 ET | 4000 | 3.649 |
02:09 ET | 1725 | 3.64 |
02:11 ET | 1700 | 3.64 |
02:13 ET | 4700 | 3.64 |
02:15 ET | 35819 | 3.65 |
02:18 ET | 6703 | 3.65 |
02:20 ET | 345 | 3.655 |
02:22 ET | 2950 | 3.655 |
02:24 ET | 4923 | 3.669 |
02:26 ET | 20536 | 3.676 |
02:27 ET | 2149 | 3.68 |
02:29 ET | 2850 | 3.67 |
02:31 ET | 500 | 3.675 |
02:33 ET | 4672 | 3.685 |
02:36 ET | 9700 | 3.68 |
02:38 ET | 4248 | 3.675 |
02:40 ET | 2545 | 3.685 |
02:42 ET | 2800 | 3.6768 |
02:44 ET | 5200 | 3.685 |
02:45 ET | 1400 | 3.69 |
02:47 ET | 4499 | 3.7 |
02:49 ET | 13559 | 3.705 |
02:51 ET | 15427 | 3.695 |
02:54 ET | 1500 | 3.7 |
02:56 ET | 15660 | 3.6845 |
02:58 ET | 5500 | 3.695 |
03:00 ET | 3660 | 3.7 |
03:02 ET | 4509 | 3.69 |
03:03 ET | 4692 | 3.675 |
03:05 ET | 5203 | 3.68 |
03:07 ET | 518 | 3.6824 |
03:09 ET | 8188 | 3.695 |
03:12 ET | 13305 | 3.7 |
03:14 ET | 320 | 3.7 |
03:16 ET | 1600 | 3.695 |
03:18 ET | 5000 | 3.698 |
03:20 ET | 1195 | 3.69 |
03:21 ET | 4600 | 3.68 |
03:23 ET | 7736 | 3.69 |
03:25 ET | 11069 | 3.69 |
03:27 ET | 1973 | 3.69 |
03:30 ET | 4918 | 3.69 |
03:32 ET | 4240 | 3.7 |
03:34 ET | 5862 | 3.69 |
03:36 ET | 3163 | 3.69 |
03:38 ET | 4898 | 3.7 |
03:39 ET | 9064 | 3.7 |
03:41 ET | 21270 | 3.7 |
03:43 ET | 6075 | 3.71 |
03:45 ET | 8090 | 3.7 |
03:48 ET | 27897 | 3.715 |
03:50 ET | 13186 | 3.7101 |
03:52 ET | 30959 | 3.725 |
03:54 ET | 15161 | 3.71 |
03:56 ET | 30626 | 3.735 |
03:57 ET | 20412 | 3.74 |
03:59 ET | 135142 | 3.75 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vaxart Inc | 442.6M | -5.9x | --- |
Mersana Therapeutics Inc | 448.1M | -1.9x | --- |
Prenetics Global Ltd | 448.4M | 29.4x | --- |
Regencell Bioscience Holdings Ltd | 448.7M | -336.8x | --- |
Monte Rosa Therapeutics Inc | 451.3M | -4.4x | --- |
Imago BioSciences Inc | 451.7M | -8.9x | --- |
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. Its programs include tablet vaccines designed to protect against coronavirus, norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV). The Company’s product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection. The Company is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $442.6M |
---|---|
Revenue (TTM) | $471.0K |
Shares Outstanding | 126.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.72 |
EPS | $-0.64 |
Book Value | $1.49 |
P/E Ratio | -5.9x |
Price/Sales (TTM) | 939.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -16,608.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.